News Focus
News Focus
icon url

hope4patients

12/13/21 7:05 AM

#426121 RE: foxhound02 #426119

The opposite is actually true. Because the company is seeking approval in 4 jurisdictions they increase the odds of regulatory approval. It’s like 4 shots on goal...actually 8 because it appears that they are also seeking approval for rGBM, which is a MUCH larger market with no effective treatment options.
icon url

iclight

12/13/21 7:07 AM

#426122 RE: foxhound02 #426119

But it would have pulled the curtain back on The Wizard's (LP) scheme much quicker.